Elsevier

Ophthalmology

Volume 94, Issue 8, August 1987, Pages 976-979
Ophthalmology

Use of BotuIinum Toxin in the Treatment of One Hundred Patients with Facial Dyskinesias

https://doi.org/10.1016/S0161-6420(87)33337-8Get rights and content

Abstract

One hundred patients with involuntary eyelid and facial spasms resulting from essential blepharospasm, Meige syndrome, and hemifacial spasm continued to respond to repeated injections of botulinum toxin at expected time intervals during a 30-month period. This series of more than 372 injections done by one of us (JAM) supports the finding of earlier, smaller series that tolerance to the toxin does not develop. The drug had a greater duration of effect in patients with hemifacial spasm than in patients with blepharospasm; the duration of effect was 17.25 weeks in the former group and 12.6 weeks in the latter. Eighteen percent of patients required a higher than standard dose for a therapeutic response. Fourteen of 15 patients with lower facial spasms and one patient with torticollis had significant relief. Dry eye may be managed by titrating the lower lid dose.

References (10)

There are more references available in the full text version of this article.

Cited by (58)

  • Drugs Used in Ophthalmology

    2020, Drug-Induced Ocular Side Effects, Eigtht Edition
  • Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment

    2017, Journal of the Neurological Sciences
    Citation Excerpt :

    They concluded that injection of botulinum toxin is effective long term treatment for oromandibular dystonia; however, jaw closure dystonia is more likely to respond than jaw opening or mixed dystonia. Mauriello et al. also reported effectiveness of botulinum toxin on lower facial spasms in 14 out of their 15 patients [81]. Rimabotulinumtoxin B has been rarely used in Meige's syndrome patients [92].

  • Part 7 - Drug-induced ocular side effects

    2014, Drug-Induced Ocular Side Effects: Clinical Ocular Toxicology
  • Botulinum neurotoxin in tremors, tics, hemifacial spasm, spasmodic dysphonia, and stuttering

    2009, Botulinum Toxin: Therapeutic Clinical Practice and Science, Expert Consult - Online and Print
  • Botulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, and Stuttering

    2009, Botulinum Toxin: Therapeutic Clinical Practice and Science
  • Drug-induced ocular side effects

    2008, Clinical Ocular Toxicology: Drug-Induced Ocular Side Effects
View all citing articles on Scopus

Presented at the American Academy of Ophthalmology Annual Meeting, New Orleans, November 1986.

View full text